Opthea Presents Additional Data from OPT-302 Phase 2b Wet AMD Trial at the Ophthalmology Innovation Summit in San Francisco

NEXT STORY
Latest Innovations in Medical Device Technologies, 2017-2019 & 2023 – Major Players are Abbott Laboratories, Boston Scientific, General Electric Co, Johnson & Johnson, and Paradromics
PREV STORY
The healthcare-associated infectious disease diagnostics market is expected to grow at a CAGR of over 8% during the period 2018–2024
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

FDA Approves G1 Therapeutics’ COSELA™ (trilaciclib): The First and Only Myeloprotection Therapy to Decrease the Incidence of Chemotherapy-Induced Myelosuppression

author_avatar
NASDAQ Market News

Cranial Implants Global Market Report 2021: COVID-19 Impact And Recovery

author_avatar
NASDAQ Market News

Adaptive and Genentech Partner to Use clonoSEQ® Assay to Measure Minimal Residual Disease as a Primary Endpoint in Phase III Study of Chronic Lymphocytic Leukemia Patients

author_avatar
NASDAQ Market News